Light therapy shows promise against HPV-Linked cervical precancer
NCT ID NCT07306247
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a treatment called photodynamic therapy (PDT) for women with low-grade cervical precancer caused by HPV types 16 or 18. A photosensitizing cream is applied to the cervix, then activated with light to destroy abnormal cells. The trial will compare 225 women who receive PDT to those who are simply observed, tracking whether the virus clears and the cervical tissue returns to normal over 24 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
aminolevulinic acid (ALA) used in photodynamic therapy (PDT)
What this could lead to
If successful, this could offer a non-surgical treatment option for cervical precancer caused by high-risk HPV types 16 and 18.
What could go wrong
This is an early-stage, non-randomized study with no control group, so results may not be definitive. The treatment requires multiple sessions and may not work for everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHOTODYNAMIC THERAPY (PDT) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
First Affiliated Hospital of Ningbo University
Ningbo, Zhejiang, 310000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
First People's Hospital of Hangzhou
Hangzhou, Zhejiang, China
Contact Phone: •••-•••-••••
-
Hangzhou Linping District first People's Hospital
Hangzhou, Zhejiang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shaoxing People's Hospital
Shaoxing, Zhejiang, 310000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Women's Hospital School Of Medicine Zhejiang University
Hangzhou, Zhejiang, 310000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••